WANG Xiaohao 1,2,3 , LI Hu 1,2,3 , ZHANG Lu 1,2,3 , CAI Dachuan 1,2,3
  • 1. Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 401336, P. R. China;
  • 2. Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Chongqing 401336, P. R. China;
  • 3. Institute for Viral Hepatitis, Chongqing Medical University, Chongqing 401336, P. R. China;
CAI Dachuan, Email: cqmucdc@cqmu.edu.cn
Export PDF Favorites Scan Get Citation

To further standardize the clinical diagnosis and treatment behavior of hepatocellular carcinoma, based on evidence-based medical evidence and expert opinion, Chinese Society of Clinical Oncology updated and published guideline of hepatocellular carcinoma. In this paper, the new guideline on the updating of medical treatment strategies for hepatocellular carcinoma was studied.

Citation: WANG Xiaohao, LI Hu, ZHANG Lu, CAI Dachuan. Study on guidelines of Chinese Society of Clinical Oncology (CSCO): hepatocellular carcinoma (2022). CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(4): 403-407. doi: 10.7507/1007-9424.202301029 Copy

  • Previous Article

    Successful management of cavernous transformation of portal vein in a child using percutaneous transhepatic portal vein recanalization by endovascular approach
  • Next Article

    Relation between marital status of patients with colorectal cancer and surgical treatment parameters: a real-world study based on DACCA